ArticleScientific reports2014
Injection-seeded optoplasmonic amplifier in the visible.
Article in Scientific reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Silica Nanospheres Coated Silver Islands as an Effective Opto-Plasmonic SERS Active Platform for Rapid and Sensitive Detection of Prostate Cancer Biomarkers.Molecules (Basel, Switzerland) · 2022Article
- Preventing tissue fibrosis by local biomaterials interfacing of specific cryptic extracellular matrix information.Nature communications · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A hybrid optoplasmonic amplifier, injection-seeded by an internally-generated Raman signal and operating in the visible (563-675 nm), is proposed and evidence for amplification is presented. Comprising a gain medium tethered to a whispering gallery mode (WGM) resonator with a protein, and a plasmonic surface, the optical system described here selectively amplifies a single (or a few) Raman line(s) produced within the WGM resonator and is well-suited for routing narrowband optical power on-a-chip. Over the past five decades, optical oscillators and amplifiers have typically been based on the buildup of the field from the spontaneous emission background. Doing so limits the temporal coherence of the output, lengthens the time required for the optical field intensity to reach saturation, and often is responsible for complex, multiline spectra. In addition to the spectral control afforded by injection-locking, the effective Q of the amplifier can be specified by the bandwidth of the injected Raman signal. This characteristic contrasts with previous WGM-based lasers and amplifiers for which the Q is determined solely by the WGM resonator.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.